Patent · US Active

Antitussive composition and method for making the same

US8257759B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER · TW

Inventors

Yuan-Ling Ku · Taipei, TW
Chien-Jen Shih · Taipei, TW
Hsiao-Chu Huang · Taipei, TW
Chun-Hung Kuo · Taoyuan, TW
Yi-Chen Lin · Taoyuan, TW
Yueh-Chu Chen · New Taipei, TW
Feng-Nien Ko · Taipei, TW

Key dates

Filing date	Dec 25, 2008
Grant date	Sep 4, 2012
Priority date	—
Expiry date	Oct 1, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.